Intuitive Surgical is a pioneering medical device company specializing in robotic-assisted surgical systems, most notably the da Vinci Surgical System. This innovative platform enhances the precision and control of minimally invasive surgical procedures, enabling surgeons to perform operations with greater accuracy and reduced recovery times for patients. The company is dedicated to advancing the field of robotics in surgery, providing training and support for healthcare professionals, and continually innovating its technology to improve patient outcomes across various medical specialties. Read More
Vessel Sealer Curved is a fully wristed, advanced bipolar electrosurgical instrument designed to seal, cut, grasp, and dissect tissue for use with Intuitive’s da Vinci surgical systems.
INTUITIVE SURGICAL (NASDAQ:ISRG) is a strong growth stock with solid fundamentals and a promising technical setup, making it a candidate for further upside.
Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital.
The select few that can do all three for many years are often the ones that make you life-changing money.
Intuitive Surgical has soared over 150% in three years. But, can the healthcare stalwart overcome tariffs and rising competition to continue winning long-term?
Over the past six months, Intuitive Surgical’s stock price fell to $516.25. Shareholders have lost 5.3% of their capital, disappointing when considering the S&P 500 was flat. This may have investors wondering how to approach the situation.
"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution.
While their quality can sometimes justify the premium, they typically experience elevated volatility during market downturns when expectations change.
Stay updated with the movements of the S&P500 index one hour before the close of the markets on Monday. Discover which stocks are leading as top gainers and losers in today's session.
Shares of medical technology company Intuitive Surgical (NASDAQ:ISRG) fell 6.2% in the afternoon session after Deutsche Bank cut the stock's rating from Hold to Sell and slashed its price target to $440 from $515, after identifying accelerating competition from lower-cost remanufactured instruments in the Instruments & Accessories segment.
